Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.998B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,577,333 | $483M | 24.2% | — | — | COM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 16,035,240 | $300M | 15.0% | — | — | COM | 75943R102 |
| WGS | GENEDX HOLDINGS CORP | 3,707,164 | $254M | 12.7% | — | — | COM CL A | 81663L200 |
| BLFS | BIOLIFE SOLUTIONS INC | 4,655,000 | $131M | 6.6% | — | — | COM NEW | 09062W204 |
| ILMN | ILLUMINA INC | 530,000 | $93.19M | 4.7% | — | — | COM | 452327109 |
| LAB | STANDARD BIOTOOLS INC | 88,783,856 | $73.04M | 3.7% | — | — | COM | 34385P108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,175,000 | $63.06M | 3.2% | — | — | SPONSORED ADS | 86366E106 |
| DNLI | DENALI THERAPEUTICS INC | 2,045,000 | $52.6M | 2.6% | — | — | COM | 24823R105 |
| NGNE | NEUROGENE INC | 1,545,361 | $48.6M | 2.4% | — | — | COM | 64135M105 |
| BEAM | BEAM THERAPEUTICS INC | 1,350,000 | $46.33M | 2.3% | — | — | COM | 07373V105 |
| TXG | 10X GENOMICS INC | 1,050,000 | $40.26M | 2.0% | — | — | CL A COM | 88025U109 |
| SRRK | SCHOLAR ROCK HLDG CORP | 665,000 | $36.58M | 1.8% | — | — | COM | 80706P103 |
| PSNL | PERSONALIS INC | 2,550,000 | $34.17M | 1.7% | — | — | COM | 71535D106 |
| GRAL | GRAIL INC | 480,000 | $32.77M | 1.6% | — | — | COM | 384747101 |
| GH | GUARDANT HEALTH INC | 185,000 | $27.76M | 1.4% | — | — | COM | 40131M109 |
| MAZE | MAZE THERAPEUTICS INC | 843,857 | $25.18M | 1.3% | — | — | COM | 578784100 |
| HIMS | HIMS & HERS HEALTH INC | 700,000 | $24.27M | 1.2% | — | — | COM CL A | 433000106 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 75,000 | $22.58M | 1.1% | — | — | COM | 02043Q107 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,250,000 | $22.13M | 1.1% | — | — | COM SHS | 877619106 |
| AGMB | AGOMAB THERAPEUTICS NV | 1,550,000 | $20.12M | 1.0% | — | — | SPONSORED ADS | 00860C102 |
| SEPN | SEPTERNA INC | 553,268 | $18.53M | 0.9% | — | — | COM | 81734D104 |
| PBLS | PARABILIS MEDICINES INC | 645,690 | $17.67M | 0.9% | — | — | COM | 698955101 |
| SION | SIONNA THERAPEUTICS INC | 400,000 | $17.6M | 0.9% | — | — | COM | 829401108 |
| VCYT | VERACYTE INC | 276,308 | $16.23M | 0.8% | — | — | COM | 92337F107 |
| ANL | ADLAI NORTYE LTD | 1,250,000 | $14.38M | 0.7% | — | — | SPONSORED ADS | 00704R109 |
| PRME | PRIME MEDICINE INC | 3,167,175 | $11.69M | 0.6% | — | — | COM | 74168J101 |
| ABSI | ABSCI CORPORATION | 973,260 | $11.28M | 0.6% | — | — | COM | 00091E109 |
| DGX | QUEST DIAGNOSTICS INC | 50,000 | $10.6M | 0.5% | — | — | COM | 74834L100 |
| SRPT | SAREPTA THERAPEUTICS INC | 470,000 | $8.446M | 0.4% | — | — | COM | 803607100 |
| QURE | UNIQURE NV | 150,000 | $6.909M | 0.3% | — | — | SHS | N90064101 |
| NTLA | INTELLIA THERAPEUTICS INC | 355,000 | $6.007M | 0.3% | — | — | COM | 45826J105 |
| MRNA | MODERNA INC | 75,000 | $5.252M | 0.3% | — | — | COM | 60770K107 |
| IRON | DISC MEDICINE INC | 65,000 | $4.754M | 0.2% | — | — | COM | 254604101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 186,014 | $4.502M | 0.2% | — | — | COM | 61225M102 |
| IPSC | CENTURY THERAPEUTICS INC | 1,228,190 | $3.009M | 0.2% | — | — | COM | 15673T100 |
| CTNM | CONTINEUM THERAPEUTICS INC | 148,333 | $2.431M | 0.1% | — | — | CL A | 21217B100 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282,312 | $2.151M | 0.1% | — | — | COM NEW | 107924102 |
| EDIT | EDITAS MEDICINE INC | 445,000 | $1.442M | 0.1% | — | — | COM | 28106W103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 723,767 | $1.216M | 0.1% | — | — | COM | 69404D108 |
| KARD | KARDIGAN INC | 50,000 | $1.192M | 0.1% | — | — | COM | 485925101 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $607K | 0.0% | — | — | CL A | 75629V104 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $362K | 0.0% | — | — | CL A NEW | 37611X209 |
| TNYA | TENAYA THERAPEUTICS INC | 361,969 | $268K | 0.0% | — | — | COM | 87990A106 |